RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Specialist | Orange, CA | $67.97 | 3 |
| Nasim Mastouri | Nephrology | Lima, OH | $67.21 | 4 |
| , MD | Internal Medicine | Washington, DC | $66.89 | 3 |
| , MD | Nephrology | South Miami, FL | $66.50 | 4 |
| , M.D | Specialist | Memphis, TN | $65.97 | 4 |
| , M.D | Nephrology | Culver City, CA | $65.97 | 4 |
| , DO | Nephrology | Livonia, MI | $65.95 | 3 |
| , MD | Nephrology | New Haven, CT | $65.90 | 3 |
| , M.D | Nephrology | Huntsville, AL | $65.74 | 4 |
| , M.D | Specialist | Exton, PA | $65.55 | 3 |
| , MD | Nephrology | South River, NJ | $65.54 | 3 |
| , M.D | Nephrology | Escondido, CA | $65.37 | 3 |
| , MD | Nephrology | Wilkesbarre, PA | $65.26 | 3 |
| , M.D | Nephrology | Milwaukee, WI | $64.86 | 4 |
| , MD | Nephrology | Washington, DC | $64.55 | 3 |
| , MD | Nephrology | Tuscaloosa, AL | $63.97 | 4 |
| , M.D | Internal Medicine | Shreveport, LA | $63.95 | 5 |
| , M.D | Nephrology | Memphis, TN | $63.24 | 4 |
| , D.O | Nephrology | Melrose Park, IL | $63.20 | 4 |
| , D.O | Nephrology | Jamesburg, NJ | $63.20 | 3 |
| , M.D | Nephrology | Leesville, LA | $63.12 | 4 |
| , M.D | Nephrology | Dayton, OH | $62.65 | 4 |
| , M.D | Nephrology | New Orleans, LA | $62.47 | 3 |
| , M.D | Internal Medicine | Chesapeake, VA | $62.13 | 4 |
| , M.D | Nephrology | Inglewood, CA | $61.98 | 4 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).